Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events
CorCal
CorCal
Sponsor study identifier
interventional
5,765
1 country
1
Study Start
March 26, 2018
Actual (reported)Primary Completion
April 6, 2026
Actual (reported)Study Completion
April 6, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, non-fatal myocardial infarction (MI), stroke, or any arterial revascularization among a moderate risk population with no current evidence of cardiovascular disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 6, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 14, 2018
Actual (reported)February 20, 2018
Actual (reported)March 26, 2018
Actual (reported)April 6, 2026
Actual (reported)April 6, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
MACE
Composite of all-cause mortality, myocardial infarction, stroke, and revascularization (coronary, carotid, and peripheral).
5 years
Standard Interventional Control Group. Will receive treatment recommendation according to the current National guidelines for statin initiation and follow-up.
Investigational Interventional Group. Will undergo coronary artery calcium screening and will receive statin recommendation based on the cardiovascular risk algorithm.
Will undergo coronary artery calcium screening and will receive statin treatment based on the cardiovascular risk algorithm.
Patients will be managed following the AHA/ACC guidelines for statin initiation and follow-up.
Intermountain Medical Center and Intermountain Clinics
Murray, Utah, 84143, United States
Anderson JL, May HT, Winslow T, Le VT, Iverson L, Bair TL, Knowlton KU, Muhlestein JB. CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics. Am Heart J. 2026 Sep;299:107473. doi: 10.1016/j.ahj.2026.107473. Epub 2026 May 7.
Muhlestein JB, Knowlton KU, Le VT, Lappe DL, May HT, Min DB, Johnson KM, Cripps ST, Schwab LH, Braun SB, Bair TL, Anderson JL. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial. JACC Cardiovasc Imaging. 2022 May;15(5):843-855. doi: 10.1016/j.jcmg.2021.11.006. Epub 2021 Dec 15.
Joseph B Muhlestein, MD
Intermountain Health Care, Inc.
5,765 participants (actual enrollment reported by the registry).
First Submitted
February 14, 2018
First Posted
February 20, 2018
Study Start
March 26, 2018
Actual (reported)Evaluating the Feasibility and Efficacy of a Real-time Smoking Intervention Using Wearable Technology
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 6, 2026
Actual (reported)Study Completion
April 6, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
April 14, 2026
Record last verified: 2026-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: